US 10913950
TMPRSS6 iRNA compositions and methods of use thereof
granted A61PA61P25/00A61P25/14
Quick answer
US patent 10913950 (TMPRSS6 iRNA compositions and methods of use thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P25/00, A61P25/14, A61P25/16, A61P25/18